Annual EBITDA
$2.65B$243.00M+10.12%
Summary
- Current Value
- As of today, ALC annual EBITDA is $2.65B, up +10.12% on
- Historical Performance
- ALC annual EBITDA is up +24.30% over the past 3 years, and up +75.51% over the past 5 years
- All-Time High Comparison
- ALC annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ALC annual EBITDA is +25.65% above its 3-year low of $2.11B reached on an earlier date
- Sector Comparison
- ALC annual EBITDA is higher than 96.44% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.65B | +10.1% | +24.3% | +75.5% | – | |
| Quarterly EBITDA | $676.00M | +4.8% | +5.3% | +82.7% | – | |
| TTM EBITDA | $2.76B | +2.7% | +21.8% | +125.5% | – | |
| Price | $81.02 | -3.2% | +13.0% | +17.2% | – | |
| PE Ratio | 38.50 | -5.9% | -63.7% | – | – | |
| Annual Revenue | $9.91B | +4.8% | +19.5% | +32.0% | – | |
| Annual EPS | $2.05 | +4.3% | +168.5% | +252.3% | +100.0% | |
| Annual EBIT | $1.42B | +20.0% | +55.9% | +1628.0% | +100.0% | |
| Annual Net Income | $1.02B | +4.5% | +170.7% | +255.2% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.65B | at high | |
| 5Y | $2.65B | at high | |
| All | $2.65B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.11B | N/A | +25.6% |
| 5Y | $1.61B | N/A | +64.4% |
| All | $1.23B | +115.4% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $2.65B | +10.1% | |
| $2.40B | +14.1% | |
| $2.11B | -1.1% | |
| $2.13B | +32.3% | |
| $1.61B | +6.8% |
| Year | Value | Change |
|---|---|---|
| $1.51B | +8.4% | |
| $1.39B | +13.2% | |
| $1.23B | -5.5% | |
| $1.30B | -22.5% | |
| $1.68B | - |
FAQ
What is the current annual EBITDA of ALC?
As of today, ALC annual EBITDA is $2.65B
What is 1-year change in ALC annual EBITDA?
ALC annual EBITDA is up +10.12% year-over-year
What is 3-year change in ALC annual EBITDA?
ALC annual EBITDA is up +24.30% over the past 3 years
How far is ALC annual EBITDA from its all-time high?
ALC annual EBITDA is currently at its all-time high
How does ALC annual EBITDA rank versus sector peers?
ALC annual EBITDA is higher than 96.44% of companies in Healthcare sector
When is ALC next annual earnings release?
As of today, the next annual earnings release for ALC has not been scheduled
Quarterly EBITDA
$676.00M$74.00M+12.29%
Summary
- Current Value
- As of today, ALC quarterly EBITDA is $676.00M, up +12.29% on
- Historical Performance
- ALC quarterly EBITDA is up +4.81% year-over-year, and up +5.30% over the past 3 years
- All-Time High Comparison
- ALC quarterly EBITDA is currently -14.54% below its historical high of $791.00M set on
- 3-Year Low Comparison
- ALC quarterly EBITDA is +46.96% above its 3-year low of $460.00M reached on an earlier date
- Sector Comparison
- ALC quarterly EBITDA is higher than 95.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $676.00M | +12.3% | +4.8% | +5.3% | +82.7% | |
| Annual EBITDA | $2.65B | – | +10.1% | +24.3% | +75.5% | |
| TTM EBITDA | $2.76B | +1.1% | +2.7% | +21.8% | +125.5% | |
| Price | $81.02 | +5.8% | -3.2% | +13.0% | +17.2% | |
| PE Ratio | 38.50 | +5.8% | -5.9% | -63.7% | – | |
| Quarterly Revenue | $2.61B | +0.7% | +6.5% | +22.1% | +42.2% | |
| Quarterly EPS | $0.48 | +35.2% | -9.6% | +103.8% | +259.0% | |
| Quarterly EBIT | $347.00M | +22.6% | +3.9% | -8.4% | +754.7% | |
| Quarterly Net Income | $237.00M | +34.7% | -9.9% | +104.3% | +261.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $791.00M | -14.5% | |
| 3Y | $791.00M | -14.5% | |
| 5Y | $791.00M | -14.5% | |
| All | $791.00M | -14.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $602.00M | +12.3% | |
| 3Y | $460.00M | N/A | +47.0% |
| 5Y | $460.00M | +47.0% | |
| All | $71.00M | +852.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALC?
As of today, ALC quarterly EBITDA is $676.00M
What is ALC quarterly EBITDA most recent change?
ALC quarterly EBITDA was up +12.29% on September 1, 2025
What is 1-year change in ALC quarterly EBITDA?
ALC quarterly EBITDA is up +4.81% year-over-year
How far is ALC quarterly EBITDA from its all-time high?
ALC quarterly EBITDA is currently -14.54% below its historical high of $791.00M set on March 31, 2025
How does ALC quarterly EBITDA rank versus sector peers?
ALC quarterly EBITDA is higher than 95.93% of companies in Healthcare sector
When is ALC next earnings release?
As of today, the next earnings release for ALC has not been scheduled
TTM EBITDA
$2.76B$31.00M+1.13%
Summary
- Current Value
- As of today, ALC TTM EBITDA is $2.76B, up +1.13% on
- Historical Performance
- ALC TTM EBITDA is up +2.67% year-over-year, and up +21.76% over the past 3 years
- All-Time High Comparison
- ALC TTM EBITDA is currently -0.11% below its historical high of $2.77B set on
- 3-Year Low Comparison
- ALC TTM EBITDA is +23.01% above its 3-year low of $2.25B reached on an earlier date
- Sector Comparison
- ALC TTM EBITDA is higher than 96.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.76B | +1.1% | +2.7% | +21.8% | +125.5% | |
| Annual EBITDA | $2.65B | – | +10.1% | +24.3% | +75.5% | |
| Quarterly EBITDA | $676.00M | +12.3% | +4.8% | +5.3% | +82.7% | |
| Price | $81.02 | +5.8% | -3.2% | +13.0% | +17.2% | |
| PE Ratio | 38.50 | +5.8% | -5.9% | -63.7% | – | |
| TTM Revenue | $10.19B | +1.6% | +4.3% | +17.1% | +49.6% | |
| TTM EPS | $2.10 | -2.3% | -10.2% | +82.2% | +243.5% | |
| TTM EBIT | $1.50B | +0.9% | +2.4% | +28.5% | +524.1% | |
| TTM Net Income | $1.05B | -2.4% | -9.8% | +83.4% | +246.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.77B | -0.1% | |
| 3Y | $2.77B | -0.1% | |
| 5Y | $2.77B | -0.1% | |
| All | $2.77B | -0.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.64B | N/A | +4.5% |
| 3Y | $2.25B | N/A | +23.0% |
| 5Y | $1.45B | N/A | +90.1% |
| All | $260.00M | +963.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALC?
As of today, ALC TTM EBITDA is $2.76B
What is ALC TTM EBITDA most recent change?
ALC TTM EBITDA was up +1.13% on September 1, 2025
What is 1-year change in ALC TTM EBITDA?
ALC TTM EBITDA is up +2.67% year-over-year
How far is ALC TTM EBITDA from its all-time high?
ALC TTM EBITDA is currently -0.11% below its historical high of $2.77B set on March 31, 2025
How does ALC TTM EBITDA rank versus sector peers?
ALC TTM EBITDA is higher than 96.21% of companies in Healthcare sector
When is ALC next earnings release?
As of today, the next earnings release for ALC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALC Official Website www.alcon.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1167379/000116737925000008/0001167379-25-000008-index.htm
- ALC Profile on Yahoo Finance finance.yahoo.com/quote/ALC
- ALC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alc